# Treatment With Prednisone of Women With RPL or RIF Positive to Antithyroid Antibodies and Embryotoxicity Test

> **NCT06641440** · PHASE4 · COMPLETED · sponsor: **Centre for Endocrinology and Reproductive Medicine, Italy** · enrollment: 42 (actual)

## Conditions studied

- Recurrent Pregnancy Loss, Not Pregnant
- Recurrent Implantation Failure

## Interventions

- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT06641440
- **Lead sponsor:** Centre for Endocrinology and Reproductive Medicine, Italy
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-10-10
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06641440

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06641440, "Treatment With Prednisone of Women With RPL or RIF Positive to Antithyroid Antibodies and Embryotoxicity Test". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06641440. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*